☆ 4.6 Article

Unremitting pyrexia, pancytopenia, hepatosplenomegaly, and extreme hyperferritinemia

AMERICAN JOURNAL OF HEMATOLOGY (2013)

Journal

AMERICAN JOURNAL OF HEMATOLOGY

Volume 88, Issue 7, Pages 626-629

Publisher

WILEY-BLACKWELL

DOI: 10.1002/ajh.23437

Keywords

-

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Medicine, General & Internal

Extreme Hyperferritinemia: Causes and Prognosis

Maxime Fauter, Sabine Mainbourg, Thomas El Jammal, Arthur Guerber, Sabine Zaepfel, Thomas Henry, Mathieu Gerfaud-Valentin, Pascal Seve, Yvan Jamilloux

Summary: This study retrospectively analyzed the diagnosis and prognosis of extreme hyperferritinemia, finding that hyperferritinemia is associated with various conditions, but extreme hyperferritinemia is only associated with four causes, with HLH and acute hepatitis being the most common. Patients with extreme hyperferritinemia have a poor prognosis and increased mortality.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Pediatrics

Germline Compound Heterozygous Variants Identified in the STXBP2 Gene Leading to a Familial Hemophagocytic Lymphohistiocytosis Type 5: A Case Report

Vera Maria Dantas, Cassandra Teixeira Valle, Roberta Piccin de Oliveira, Mylena Taise Azevedo L. Bezerra, Cleia Teixeira do Amaral, Raissa Anielle S. Brandao, Jussara M. Cerqueira Maia, Tirzah Braz Petta

Summary: The study reported a case of a 2-year-old boy diagnosed with Familial Hemophagocytic Lymphohistiocytosis (FHL) type 5. Genetic analysis revealed a compound heterozygosity of STXBP2 gene, and the patient responded well to HLH-2004 protocol treatment with the possibility of hematopoietic stem cell transplantation (HSCT) in the future.

FRONTIERS IN PEDIATRICS (2021)

Add to Collection

Review Emergency Medicine

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN THE EMERGENCY DEPARTMENT: RECOGNIZING AND EVALUATING A HIDDEN THREAT

Katelin Morrissette, Rachel Bridwell, Skyler Lentz, Elizabeth Brem, Karla Olmedo Gutierrez, Manpreet Singh, Alex Koyfman, Brit Long

Summary: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hematologic disorder that can mimic other common conditions such as sepsis and flu-like illnesses. Although rare, HLH has high mortality rates, which increase with delays in treatment.

JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection

Article Transplantation

Visceral Leishmaniasis After Kidney Transplant: An Unusual Presentation and Mode of Diagnosis

Abhyudaysingh Rana, Ashwini Gadde, Lipika Lippi, Shyam B. Bansal

Summary: Infection caused by Leishmania species has been increasingly reported in solid-organ transplant recipients. Early diagnosis of this endemic infection is likely to result in improved outcome. We describe an unusual presentation of leishmaniasis in a kidney transplant recipient, without fever but with organomegaly and pancytopenia.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2022)

Add to Collection

Article Endocrinology & Metabolism

Extreme hyperferritinemia in the pediatric emergency setting: haemophagocytic lymphohistiocytosis, macrophage activation syndrome, sepsis and more

C. Scozzafava, S. Sestito, D. Concolino, A. Giannotta, M. Miraglia Del Giudice, G. F. Parisi, G. Ceravolo, C. Cuppari, L. Pensabene, D. Sutera, A. Spagnuolo, R. Gallizzi

Summary: Conditions such as HLH, MAS, sepsis, and MIS-C share similarities in clinical and laboratory aspects, including elevated ferritin levels. Therefore, in pediatric emergency settings, high ferritin levels accompanied by fever should prompt consideration of these rare syndromes for timely therapy.

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS (2022)

Add to Collection

Article Medicine, General & Internal

A Case of Leishmaniasis Infantum Kala-Azar in an Immunocompetent 49-Year-Old Man

Carla Williams, Jessica Bass, Anshika Singh, Kelsey Diemer

Summary: A 45-year-old Cuban-American man presented with worsening knee pain and swelling. Physical examination revealed cachexia, a protuberant abdomen, and massive splenomegaly. Lab tests showed pancytopenia, hyponatremia, hypoalbuminemia, and anemia of chronic inflammation. Bone marrow biopsy confirmed the diagnosis of leishmaniasis.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Add to Collection

Article Oncology

Extreme elevation of acute phase reactants and shock secondary to dabrafenib-trametinib

Pablo Ayala de Miguel, Itziar Gorospe Garcia, Javier Lopez Gallego, Pablo Borrega Garcia

Summary: The emerging role of BRAF and MEK tyrosine-kinase inhibitors provides new treatment opportunities for patients with advanced melanoma and BRAF mutations, but may be associated with toxicities. This case report describes a patient who developed multiple episodes of fever, hypotension, and acute phase reactants elevation while on dabrafenib and trametinib therapy, initially managed as septic shock without evidence of infection. After dose reduction of dabrafenib, the fever episodes resolved.

MELANOMA RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Hereditary Hyperferritinemia Cataract Syndrome: Ferritin L Gene and Physiopathology behind the Disease-Report of New Cases

Ferran Celma Nos, Gonzalo Hernandez, Xenia Ferrer-Cortes, Ines Hernandez-Rodriguez, Begona Navarro-Almenzar, Jose Luis Fuster, Mar Bermudez Cortes, Santiago Perez-Montero, Cristian Tornador, Mayka Sanchez

Summary: Hereditary hyperferritinemia-cataract syndrome is a rare disease caused by mutations in the FTL gene's IRE, resulting in excess ferritin production and cataract formation. Diagnosis should include testing serum ferritin levels for early detection and management.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Hematology

A newly identified ferritin L-subunit variant results in increased proteasomal subunit degradation, impaired complex assembly, and severe hypoferritinemia

Dayana Shagidov, Noga Guttmann-Raviv, Severine Cunat, Liora Frech, Muriel Giansily-Blaizot, Niraj Ghatpande, Gili Abelya, Gabriel A. Frank, Patricia Aguilar Martinez, Esther G. Meyron-Holtz

Summary: This study described a female patient with severe hypoferritinemia without anemia. After inadequate heavy IV iron supplementation, the patient developed severe iron overload and musculoskeletal manifestations. Genetic analysis revealed an undescribed homozygous variant of FTL, which may result in incomplete assembly of ferritin nanocages and lead to low serum ferritin levels. This study emphasizes the importance of a broader diagnostic approach for hypoferritinemia without anemia before IV iron supplementation.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Fever of Unknown Origin (FUO)-A Call for New Research Standards and Updated Clinical Management

William F. Wright, Catharina M. Mulders-Manders, Paul G. Auwaerter, Chantal P. Bleeker-Rovers

Summary: Fever of unknown origin refers to prolonged fever of at least 3 weeks' duration, with a temperature of 38.3 degrees C or higher, that remains unexplained after preliminary investigations. Recent advancements in diagnosis, management, and diagnostic testing have prompted a revision of the definition and approaches to fever of unknown origin. The updated definition includes a lower temperature threshold and revised minimum testing criteria, providing a solid foundation for clinicians and future research.

AMERICAN JOURNAL OF MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

Pituitary and SARS CoV-2: An unremitting conundrum

Cristina Capatina, Catalina Poiana, Maria Fleseriu

Summary: There is increasing interest in understanding how COVID-19 affects the endocrine system, specifically the pituitary gland. Studies have shown that COVID-19 can lead to various pituitary dysfunctions, such as hypopituitarism, pituitary apoplexy, and hypophysitis. Patients with pre-existing pituitary conditions, such as acromegaly, Cushing's disease, and hypopituitarism, may have an increased risk of complications with COVID-19. Further research is still being conducted to fully understand the impact of COVID-19 on pituitary function.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Add to Collection

Article Oncology

Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma

Morgan Homan, Govind Warrier, Christopher D. Lao, Sarah Yentz, Shawna Kraft, Leslie A. Fecher

Summary: This study describes the treatment-related toxicities of adjuvant dabrafenib and trametinib combination therapy for patients with resected melanoma and finds that the majority of patients experience treatment-limiting toxicities. Therefore, close monitoring of patients is necessary during treatment.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Pediatrics

Unremitting Pain and Fever in a 15-Year-Old Boy With Osteomyelitis

Kathryn S. Cain, Avinash K. Shetty, Lindsay Strowd, Omar Sangueza, Nicholas M. Potisek

Summary: A 15-year-old boy presented to multiple hospitals with suspected osteomyelitis-induced toe infection, but his condition worsened after diagnosis and treatment, eventually leading to the discovery of lung abnormalities.

PEDIATRICS (2021)

Add to Collection

Article Veterinary Sciences

Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia

Melissa A. Mercer, Jennifer L. Davis, Harold C. McKenzie, Kristen M. Messenger, Emily Schaefer, R. McAlister Council-Troche, Stephen R. Werre

Summary: This study aimed to evaluate the pharmacokinetics and efficacy of acetaminophen as an antipyretic in horses. The results showed that acetaminophen significantly reduced rectal temperature in horses and had a similar antipyretic effect as flunixin meglumine. It can be used as an alternative for antipyresis in clinical cases, especially when traditional NSAIDs are contraindicated.

JOURNAL OF VETERINARY INTERNAL MEDICINE (2023)

Add to Collection

Article Oncology

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements

Alia Thawer, Wilson H. Miller Jr, Nancy Gregorio, Joel Claveau, Sudha Rajagopal, Kerry J. Savage, Xinni Song, Teresa M. Petrella

Summary: The combination treatment of dabrafenib and trametinib for BRAF-mutated melanoma can lead to pyrexia syndrome in at least 50% of patients, which if not managed properly, can worsen and cause complications. Despite various therapeutic approaches suggested in the literature, a Canadian working group developed a pyrexia treatment algorithm to provide practical guidance for managing this side effect.

CURRENT ONCOLOGY (2021)

Add to Collection

Article Plant Sciences

Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids

Wei Meng, Wai Ling Lin, Wing Fai Yeung, Yangbo Zhang, Ernest Hung Yu Ng, Yuen Phin Elaine Lee, Zhang-Jin Zhang, Jianhui Rong, Lixing Lao

Summary: The study aimed to compare the efficacy and safety of a modified herbal formula Guizhi Fuling Wan at conventional and low doses in treating symptomatic uterine fibroids. Both doses showed significant improvement in symptoms and fibroid volume, with no significant difference between them. The herbal formula was found to be safe for women with uterine fibroids.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Add to Collection

Article Immunology

Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study

Eric Yuk Fai Wan, Celine Sze Ling Chui, Vanessa Wai Sei Ng, Yuan Wang, Vincent Ka Chun Yan, Ivan Chun Hang Lam, Min Fan, Francisco Tsz Tsun Lai, Esther Wai Yin Chan, Xue Li, Carlos King Ho Wong, Raccoon Ka Cheong Chung, Benjamin John Cowling, Wing Chi Fong, Alexander Yuk Lun Lau, Vincent Chung Tong Mok, Frank Ling Fung Chan, Cheuk Kwong Lee, Lot Sze Tao Chan, Dawin Lo, Kui Kai Lau, Ivan Fan Ngai Hung, Chak Sing Lau, Gabriel Matthew Leung, Ian Chi Kei Wong

Summary: Based on electronic health records in Hong Kong, the risk of Bell's palsy increased following BNT162b2 vaccination, particularly within 14 days after the second dose. However, the absolute risk remains very low, so the benefits of COVID-19 vaccination still outweigh the small risk of Bell's palsy.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial

Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok Cheung Lung, Raymond Liu, Ka Yi Leung, Danlei Liu, Yujing Fan, Lu Lu, Athene Hoi Ying Lam, Tom Wai Hin Chung, Cyril Chik Yan Yip, Jenny Lo, Alan Ka Lun Wu, Rodney Lee, Simon Sin, Pauline Yeung Ng, Wai Ming Chan, Hoi Ping Shum, Wing Wa Yan, Jasper Fuk Woo Chan, Vincent Chi Chung Cheng, Chak Sing Lau, Kelvin Kai-Wang, Kwok Hung Chan, Kwok Yung Yuen, Ivan Fan Ngai Hung

Summary: Combined treatment with interferon beta-1b and remdesivir is more effective than remdesivir alone in the treatment of COVID-19, providing relief for symptoms, reducing viral shedding and hospitalization time, and inducing earlier antibody response in high-risk patients.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Oncology

SURPASS-ET: phase III study of ropeginterferon alfa-2b versus anagrelide as second-line therapy in essential thrombocythemia

Srdan Verstovsek, Norio Komatsu, Harinder Gill, Jie Jin, Sung-Eun Lee, Hsin-An Hou, Toshiaki Sato, Albert Qin, Raymond Urbanski, Weichung Shih, Oleh Zagrijtschuk, Craig Zimmerman, Ruben A. Mesa

Summary: Patients diagnosed with high-risk essential thrombocythemia (ET) have limited treatment options. Hydroxyurea is the recommended treatment, but many patients experience resistance or intolerance. This article introduces interferon as a potential second-line therapy and mentions an ongoing clinical trial (SURPASS-ET) that will evaluate the efficacy and safety of a new type of interferon (ropeginterferon alfa-2b) compared to anagrelide.

FUTURE ONCOLOGY (2022)

Add to Collection

Article Rheumatology

Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study

Kathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, Laniyati Hamijoyo, Shue Fen Luo, Yeong-Jian Jan Wu, Jiacai Cho, Aisha Lateef, C. S. Lau, Yi-Hsing Chen, Sandra Navarra, Leonid Zamora, Zhanguo Li, Yuan An, Sargunan Sockalingam, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Yasuhiro Katsumata, Masayoshi Harigai, Shereen Oon, Sang-Cheol Bae, Sean O'Neill, Kathryn A. Gibson, B. M. D. B. Basnayake, Jun Kikuchi, Tsutomu Takeuchi, Kristine Pek Ling Ng, Nicola Tugnet, Sunil Kumar, Fiona Goldblatt, Annie Law, Michael Tee, Cherica Tee, Yoshiya Tanaka, Naoaki Ohkubo, Jin Yu Tan, Chetan S. Karyekar, Mandana Nikpour, Vera Golder, Eric F. Morand

Summary: In long-term follow-up of patients with systemic lupus erythematosus, attainment of a modified version of the SLE Responder Index (mSRI) predicts favorable outcomes and supports the clinical meaningfulness of SRI attainment as an SLE trial end point.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Review Pharmacology & Pharmacy

The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases

Lynn Chin, Cyrus R. Kumana, Yok-Lam Kwong, Harinder Gill

Summary: Appreciation of the properties of arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukaemia (APL) and holds promise for numerous other diseases. ATO's ability to counteract the effects of the oncoprotein PML::RARA, found in APL patients, has made it a curative treatment when combined with all-trans retinoic acid. Additionally, ATO's multiple mechanisms of action have opened up possibilities for its use in various autoimmune or inflammatory disorders, solid organ tumors, lymphomas, and other subtypes of AML. The development of oral ATO has improved treatment convenience and accessibility.

PHARMACEUTICS (2022)

Add to Collection

Article Allergy

Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination

Andy Ka Chun Kan, Thomas Tsz Hang Wong, Valerie Chiang, Chak Sing Lau, Philip Hei Li

Summary: This study investigated the clinical characteristics of chronic spontaneous urticaria (CSU) patients in Hong Kong and the role of an immunologist-led Urticaria Clinic, as well as the impact of CSU on COVID-19 vaccine uptake. The results showed that the Urticaria Clinic can effectively improve the management and outcomes of CSU.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2023)

Add to Collection

Article Multidisciplinary Sciences

Health-related quality of life in Hong Kong physicians up to 20 years post-graduation: A cross-sectional survey

Amy Pui Pui Ng, Weng Yee Chin, Eric Yuk Fai Wan, Julie Chen, Chak Sing Lau

Summary: This study compared the health-related quality of life of Hong Kong physicians to the general population and explored the factors associated with mental and physical health-related quality of life. Results showed that doctors had worse mental health compared to the general population. Regular exercise was positively associated with physical health, while having children and higher personal burnout scores were negatively associated with it. Poorer mental health was correlated with worse burnout, depression, and patient-related burnout.

PLOS ONE (2023)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Shedding Light on Skin Autoimmunity: More than Just Skin Deep

Philip Hei Li, Chak-sing Lau

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Medicine, General & Internal

Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non- hospitalised and hospitalised patients with COVID-19: a target trial emulation study

Eric Yuk Fai Wan, Vincent Ka Chun Yan, Zoey Cho Ting Wong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Ivan Fan Ngai Hung, Chak Sing Lau, Ian Chi Kei Wong, Esther Wai Yin Chan

Summary: The study found that Nirmatrelvir-Ritonavir was more effective than Molnupiravir in reducing the risk of all-cause mortality in both non-hospitalised and hospitalised patients with COVID-19. Nirmatrelvir-Ritonavir users had lower risks of all-cause mortality and hospital admission compared to Molnupiravir users, while there was no difference in the risk of intensive care unit admission or ventilatory support between the two drugs.

ECLINICALMEDICINE (2023)

Add to Collection

Article Immunology

Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells

Mo Yin Mok, Ka Sin Law, Wing Yin Kong, Cai Yun Luo, Endale T. Asfaw, Kwok Wah Chan, Fang Ping Huang, Chak Sing Lau, Godfrey Chi Fung Chan

Summary: This study found that exogenous IL-33 can ameliorate disease activity in lupus-prone mice by inducing M2 polarization, Th2 response, and expansion of regulatory T cells. This is likely achieved through upregulation of ST2 expression, orchestrating autoregulation of these cells.

JOURNAL OF INNATE IMMUNITY (2023)

Add to Collection

Article Rheumatology

A case report of rheumatoid neutrophilic dermatitis in a Chinese woman with seropositive rheumatoid arthritis

Cheuk Ying Karen Ho, Tiffany Wing-See Lau, Ho Yin Chung, Carmen Tze Kwan Ho, Chak Sing Lau

Summary: This article reports a rare case of extra-articular manifestation in RA, where the patient developed RND on the skin. RA and RND were successfully controlled with rituximab therapy. The importance of clinical presentations and differential diagnoses were also discussed in this article.

MODERN RHEUMATOLOGY CASE REPORTS (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Association between High Diffusion-Weighted Imaging-Derived Functional Tumor Burden of Peritoneal Carcinomatosis and Overall Survival in Patients with Advanced Ovarian Carcinoma

He An, Jose A. U. Perucho, Keith W. H. Chiu, Edward S. Hui, Mandy M. Y. Chu, Siew Fei Ngu, Hextan Y. S. Ngan, Elaine Y. P. Lee

Summary: This study investigated the association between functional tumor burden of peritoneal carcinomatosis derived from DWI and overall survival in patients with advanced ovarian carcinoma. The results showed that a high DWI-derived functional tumor burden was associated with decreased overall survival.

KOREAN JOURNAL OF RADIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Regression of IgG4-related coronary arteritis and aortitis with immunosuppressive therapy

Yiu-Hei Tse, Sherwin Shing-Wai Lo, Chak-Sing Lau, Hung-Fat Tse

EUROPEAN HEART JOURNAL-CASE REPORTS (2022)

Add to Collection

Article Rheumatology

'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study

Rangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, Shue-Fen Luo, Yeong-Jian J. Wu, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Sandra Navarra, Leonid Zamora, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, Jun Kikuchi, Tsutomu Takeuchi, B. M. D. B. Basnayake, Madelynn Chan, Kristine Pek Ling Ng, Nicola Tugnet, Sunil Kumar, Shereen Oon, Fiona Goldblatt, Sean O'Neill, Kathryn A. Gibson, Naoaki Ohkubo, Yoshiya Tanaka, Sang-Cheol Bae, Chak Sing Lau, Mandana Nikpour, Vera Golder, Eric F. Morand

Summary: This study found a high prevalence of failure to achieve low disease activity state, high average disease activity, and episodes of high disease activity in SLE patients, which were significantly associated with poor outcomes including organ damage, glucocorticoid exposure, poor quality of life, and mortality.

ARTHRITIS RESEARCH & THERAPY (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.